Literature DB >> 6642640

Production of cholera toxin-like toxin by Vibrio mimicus and non-O1 Vibrio cholerae: batch culture conditions for optimum yields and isolation of hypertoxigenic lincomycin-resistant mutants.

W M Spira, P J Fedorka-Cray.   

Abstract

Vibrio mimicus 61892, isolated in 1977 from a case of watery diarrhea in Bangladesh, produces an enterotoxin which possesses activity in Y-1 mouse adrenal cells and in rabbit ileal loops which is identical to the prototype cholera toxin (CT) produced by Vibrio cholerae 569B. The neutralization of the adrenal cell activity of 61892 toxin and 569B CT by homologous and heterologous antisera generates parallel titration curves which show complete neutralization in all cases. Paired titrations in the ganglioside GM1 enzyme-linked immunosorbent assay (using either CT or Escherichia coli heat-labile toxin antitoxin) of both toxins indicates that 61892 toxin is antigenically indistinguishable from 569B CT. The specific activity of the two toxins in the rabbit ileal loop is virtually identical. Batch culture production of CT-like toxin and CT by isolates of V. mimicus and different biotypes of V. cholerae was found to be highest in shake flask cultures of Casamino Acids-yeast extract broth grown at 27 degrees C with vigorous aeration. Incorporation of lincomycin into the growth medium at a concentration of 50 micrograms/ml increased yields from wild-type strains. Dramatically higher yields were obtained when a spontaneous resistance mutant of strain 61892 was grown in the presence of 200 to 300 micrograms of lincomycin per ml. Under these conditions, yields of CT-like toxin were increased by 300- to 500-fold, and the highest yields reached more than 100 micrograms/ml after 44 h of culture. This is substantially higher than that reported in the literature for CT production by any strain of V. cholerae, including hypertoxigenic strain 569B.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6642640      PMCID: PMC264457          DOI: 10.1128/iai.42.2.501-509.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Production of Biologically Active Substances by Two Strains of Vibrio cholerae.

Authors:  H Kusama; J P Craig
Journal:  Infect Immun       Date:  1970-01       Impact factor: 3.441

2.  Enterotoxicity of the so-called NAG vibrios.

Authors:  S J Singh; S C Sanyal
Journal:  Ann Soc Belg Med Trop       Date:  1978

3.  In vitro production of enterotoxin and hemorrhagic principle by Vibrio cholerae, NAG.

Authors:  M Oashi; T Shimada; H Fukumi
Journal:  Jpn J Med Sci Biol       Date:  1972-06

4.  Permeability and enterotoxic factors of nonagglutinable vibrios Vibrio alcaligenes and Vibrio parahaemolyticus.

Authors:  S Bhattacharya; A K Bose; A K Ghosh
Journal:  Appl Microbiol       Date:  1971-12

5.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

6.  Induction of Escherichia coli and Vibrio cholerae enterotoxins by an inhibitor of protein synthesis.

Authors:  M Levner; F P Wiener; B A Rubin
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

7.  Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside.

Authors:  J L Tayot; J Holmgren; L Svennerholm; M Lindblad; M Tardy
Journal:  Eur J Biochem       Date:  1981-01

8.  Cholera--a possible endemic focus in the United States.

Authors:  P A Blake; D T Allegra; J D Snyder; T J Barrett; L McFarland; C T Caraway; J C Feeley; J P Craig; J V Lee; N D Puhr; R A Feldman
Journal:  N Engl J Med       Date:  1980-02-07       Impact factor: 91.245

9.  Purification and some properties of a non-o1 Vibrio cholerae enterotoxin that is identical to cholera enterotoxin.

Authors:  K Yamamoto; Y Takeda; T Miwatani; J P Craig
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Characterization of biochemically atypical Vibrio cholerae strains and designation of a new pathogenic species, Vibrio mimicus.

Authors:  B R Davis; G R Fanning; J M Madden; A G Steigerwalt; H B Bradford; H L Smith; D J Brenner
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

View more
  7 in total

1.  Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin.

Authors:  R J Almeida; F W Hickman-Brenner; E G Sowers; N D Puhr; J J Farmer; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 2.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

3.  Infectious CTXPhi and the vibrio pathogenicity island prophage in Vibrio mimicus: evidence for recent horizontal transfer between V. mimicus and V. cholerae.

Authors:  E F Boyd; K E Moyer; L Shi; M K Waldor
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Purification of enterotoxins from Vibrio mimicus that appear to be identical to cholera toxin.

Authors:  W M Spira; P J Fedorka-Cray
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

5.  Characterization of toxigenic vibrios isolated from the freshwater environment of Hiroshima, Japan.

Authors:  K Venkateswaran; C Kiiyukia; M Takaki; H Nakano; H Matsuda; H Kawakami; H Hashimoto
Journal:  Appl Environ Microbiol       Date:  1989-10       Impact factor: 4.792

6.  Comparative study of expression of hemagglutinins, hemolysins, and enterotoxins by clinical and environmental isolates of non-O1 Vibrio cholerae in relation to their enteropathogenicity.

Authors:  K Datta-Roy; K Banerjee; S P De; A C Ghose
Journal:  Appl Environ Microbiol       Date:  1986-10       Impact factor: 4.792

7.  New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor.

Authors:  M Iwanaga; K Yamamoto
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.